SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-18-044262
Filing Date
2018-08-14
Accepted
2018-08-14 09:02:55
Documents
43
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tv499145_10q.htm 10-Q 470888
2 EXHIBIT 3.1 tv499145_ex3-1.htm EX-3.1 7756
3 EXHIBIT 31.1 tv499145_ex31-1.htm EX-31.1 10010
4 EXHIBIT 31.2 tv499145_ex31-2.htm EX-31.2 9736
5 EXHIBIT 32.1 tv499145_ex32-1.htm EX-32.1 3801
6 EXHIBIT 32.2 tv499145_ex32-2.htm EX-32.2 3672
  Complete submission text file 0001144204-18-044262.txt   2137564

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT atxi-20180630.xml EX-101.INS 352195
8 XBRL TAXONOMY EXTENSION SCHEMA atxi-20180630.xsd EX-101.SCH 21756
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE atxi-20180630_cal.xml EX-101.CAL 21227
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE atxi-20180630_def.xml EX-101.DEF 143126
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE atxi-20180630_lab.xml EX-101.LAB 156570
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atxi-20180630_pre.xml EX-101.PRE 163867
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 781-652-4500
AVENUE THERAPEUTICS, INC. (Filer) CIK: 0001644963 (see all company filings)

IRS No.: 474113275 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 10-Q | Act: 34 | File No.: 001-38114 | Film No.: 181014555
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1